Beer TM - Search Results

1

Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer.

Chen WS, Aggarwal R, Zhang L, Zhao SG, Thomas GV, Beer TM, Quigley DA, Foye A, Playdle D, Huang J, Lloyd P, Lu E, Sun D, Guan X, Rettig M, Gleave M, Evans CP, Youngren J, True L, Lara P, Kothari V, Xia Z, Chi KN, Reiter RE, Maher CA, Feng FY, Small EJ, Alumkal JJ; West Coast Prostate Cancer Dream Team. Chen WS, et al. Among authors: beer tm. Eur Urol. 2019 Nov;76(5):562-571. doi: 10.1016/j.eururo.2019.03.020. Epub 2019 Mar 28. Eur Urol. 2019. PMID: 30928160 Free PMC article.

2

Successful treatment of metastatic hormone-refractory prostate cancer with malignant pericardial tamponade using docetaxel.

Hayes-Lattin BM, Kovach PA, Henner WD, Beer TM. Hayes-Lattin BM, et al. Among authors: beer tm. Urology. 2002 Jan;59(1):137. doi: 10.1016/s0090-4295(01)01481-9. Urology. 2002. PMID: 11796304

3

Unilateral autonomous testicular testosterone production mimicking androgen independent prostate cancer.

Lavelle M, Schuff KG, Keller FS, Binkert CA, O'Hara M, Fairfax CA, Beer TM. Lavelle M, et al. Among authors: beer tm. J Urol. 2002 Sep;168(3):1098-9. doi: 10.1016/S0022-5347(05)64586-7. J Urol. 2002. PMID: 12187234 No abstract available.

4

Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapy.

Beer TM, Garzotto M, Eilers KM, Lemmon D. Beer TM, et al. J Urol. 2003 May;169(5):1738-41. doi: 10.1097/01.ju.0000059584.47272.9d. J Urol. 2003. PMID: 12686821 Clinical Trial.

5

Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomy.

Beer TM, Garzotto M, Eilers KM, Lemmon D, Wersinger EM. Beer TM, et al. Urology. 2004 Feb;63(2):342-7. doi: 10.1016/j.urology.2003.09.045. Urology. 2004. PMID: 14972486

6

Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer.

Tiffany NM, Wersinger EM, Garzotto M, Beer TM. Tiffany NM, et al. Among authors: beer tm. Urology. 2004 May;63(5):934-9. doi: 10.1016/j.urology.2003.12.022. Urology. 2004. PMID: 15134984 Clinical Trial.

7

Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894.

Beer TM, Tangen CM, Bland LB, Thompson IM, Crawford ED. Beer TM, et al. J Urol. 2004 Dec;172(6 Pt 1):2213-7. doi: 10.1097/01.ju.0000147771.92104.83. J Urol. 2004. PMID: 15538234

8

Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer.

Wagner M, Garzotto M, Lemmon D, Eilers KM, Beer TM. Wagner M, et al. Among authors: beer tm. Urology. 2005 Apr;65(4):799. doi: 10.1016/j.urology.2004.10.059. Urology. 2005. PMID: 15833548

9

High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study.

Tiffany NM, Ryan CW, Garzotto M, Wersinger EM, Beer TM. Tiffany NM, et al. Among authors: beer tm. J Urol. 2005 Sep;174(3):888-92. doi: 10.1097/01.ju.0000169261.42298.e6. J Urol. 2005. PMID: 16093981 Clinical Trial.

10

Testosterone loss and estradiol administration modify memory in men.

Beer TM, Bland LB, Bussiere JR, Neiss MB, Wersinger EM, Garzotto M, Ryan CW, Janowsky JS. Beer TM, et al. J Urol. 2006 Jan;175(1):130-5. doi: 10.1016/S0022-5347(05)00049-2. J Urol. 2006. PMID: 16406889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

299 results

Search Page